Akoya Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Akoya Biosciences
AKYA Stock  USD 2.14  0.06  2.73%   
Akoya Biosciences financial statements provide useful quarterly and yearly information to potential Akoya Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Akoya Biosciences financial statements helps investors assess Akoya Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Akoya Biosciences' valuation are summarized below:
Gross Profit
43.4 M
Profit Margin
(0.65)
Market Capitalization
106.1 M
Enterprise Value Revenue
1.7864
Revenue
93.2 M
We have found one hundred twenty available fundamental signals for Akoya Biosciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Akoya Biosciences prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.

Akoya Biosciences Total Revenue

68.44 Million

Check Akoya Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akoya Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 40.8 K, Depreciation And Amortization of 6 M or Interest Expense of 4.6 M, as well as many indicators such as Price To Sales Ratio of 2.13, Dividend Yield of 0.002 or PTB Ratio of 4.85. Akoya financial statements analysis is a perfect complement when working with Akoya Biosciences Valuation or Volatility modules.
  
Check out the analysis of Akoya Biosciences Correlation against competitors.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.

Akoya Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets157.2 M180.4 M111.8 M
Slightly volatile
Short and Long Term Debt Total55.9 M85.7 M35.5 M
Slightly volatile
Total Current Liabilities30.4 M35.3 M23.9 M
Slightly volatile
Other Liabilities7.1 M7.4 M9 M
Slightly volatile
Property Plant And Equipment Net13.4 M20.7 M8 M
Slightly volatile
Current Deferred Revenue5.6 M6.7 M4.7 M
Slightly volatile
Accounts Payable12.9 M11.8 M9.7 M
Slightly volatile
Cash65.8 M83.1 M31.3 M
Slightly volatile
Non Current Assets Total59.4 M58.6 M51.1 M
Slightly volatile
Non Currrent Assets Other2.7 M2.2 M1.7 M
Slightly volatile
Other Assets0.951.01.4 M
Pretty Stable
Long Term Debt50.4 M75.3 M33.3 M
Slightly volatile
Cash And Short Term Investments69.5 M83.1 M38.7 M
Slightly volatile
Net Receivables12.3 M17 M12.4 M
Pretty Stable
Good Will14.6 M16.4 M17.9 M
Slightly volatile
Common Stock Total Equity1.6 K2.3 K1.3 K
Slightly volatile
Common Stock Shares Outstanding42.6 M44.4 M38 M
Slightly volatile
Liabilities And Stockholders Equity157.2 M180.4 M111.8 M
Slightly volatile
Non Current Liabilities Total77.9 M91.3 M87.8 M
Slightly volatile
Capital Lease Obligations5.3 M10.5 M2.1 M
Slightly volatile
Inventory10.9 M17.9 M6.5 M
Slightly volatile
Other Current Assets5 M3.8 M3 M
Slightly volatile
Other Stockholder Equity160 M283.8 M59.1 M
Slightly volatile
Total Liabilities108.3 M126.6 M111.8 M
Slightly volatile
Property Plant And Equipment Gross16.5 M30.3 M9.1 M
Slightly volatile
Total Current Assets97.8 M121.8 M60.7 M
Slightly volatile
Capital Stock1.7 K1.8 K836.6 K
Slightly volatile
Non Current Liabilities Other10.4 M5.8 M8.7 M
Slightly volatile
Net Working Capital67.3 M86.4 M36.7 M
Slightly volatile
Short Term Debt3.5 M6.9 M1.3 M
Slightly volatile
Intangible Assets16.9 M17.4 M22.6 M
Slightly volatile
Common Stock2 K2.3 K1.4 K
Slightly volatile
Property Plant Equipment7.7 M11.7 M6.2 M
Slightly volatile
Deferred Long Term Liabilities101.9 K78.3 K216.8 K
Slightly volatile
Short and Long Term Debt825.6 K928.8 K1 M
Slightly volatile
Long Term Debt Total52.7 M72.8 M38.6 M
Slightly volatile
Capital Surpluse243.5 M259.1 M222.5 M
Slightly volatile

Akoya Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization6 M8.9 M3.8 M
Slightly volatile
Interest Expense4.6 M8.8 M2.8 M
Slightly volatile
Selling General Administrative58.6 M84.4 M36.9 M
Slightly volatile
Selling And Marketing Expenses720 K810 K882 K
Slightly volatile
Total Revenue68.4 M96.6 M50.6 M
Slightly volatile
Gross Profit40.6 M56.3 M29.8 M
Slightly volatile
Other Operating Expenses109.4 M154.3 M73.9 M
Slightly volatile
Research Development17.4 M21.9 M11.7 M
Slightly volatile
Cost Of Revenue27.9 M40.3 M20.8 M
Slightly volatile
Total Operating Expenses79.4 M104.3 M52.3 M
Slightly volatile
Reconciled Depreciation6 M8.7 M4.1 M
Slightly volatile
Interest Income3.3 M3.1 M553.9 K
Slightly volatile
Preferred Stock And Other Adjustments1.1 M1.3 M1.4 M
Slightly volatile

Akoya Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation11 M10.4 M2.3 M
Slightly volatile
Begin Period Cash Flow50.1 M74.5 M24.7 M
Slightly volatile
Depreciation6.1 M8.9 M4.1 M
Slightly volatile
Capital Expenditures4.9 M3.7 M3.5 M
Slightly volatile
Issuance Of Capital Stock63.7 M48 M45.7 M
Slightly volatile
Total Cash From Financing Activities56.5 M56.8 M38 M
Slightly volatile
End Period Cash Flow66.3 M83.8 M31.8 M
Slightly volatile
Dividends Paid1.1 M1.3 M1.4 M
Slightly volatile
Other Cashflows From Investing Activities44 K49.5 K53.9 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.132.24414.19
Slightly volatile
Dividend Yield0.0020.00230.0025
Slightly volatile
Days Sales Outstanding75.6464.189496.2371
Slightly volatile
Stock Based Compensation To Revenue0.110.1080.0292
Slightly volatile
Capex To Depreciation0.390.41090.8766
Slightly volatile
EV To Sales2.162.270714.3325
Slightly volatile
Inventory Turnover3.282.25593.7878
Slightly volatile
Days Of Inventory On Hand107162103
Slightly volatile
Payables Turnover2.243.42462.3815
Slightly volatile
Sales General And Administrative To Revenue0.480.540.5902
Slightly volatile
Research And Ddevelopement To Revenue0.20.22650.2215
Slightly volatile
Capex To Revenue0.03590.03780.0681
Pretty Stable
Cash Per Share1.31.87070.9759
Slightly volatile
Days Payables Outstanding149107156
Slightly volatile
Income Quality0.60.80380.85
Slightly volatile
Intangibles To Total Assets0.350.19780.4161
Slightly volatile
Current Ratio2.423.44572.3316
Slightly volatile
Receivables Turnover4.635.68634.1642
Slightly volatile
Graham Number4.546.2293.8142
Slightly volatile
Capex Per Share0.0960.08220.0914
Slightly volatile
Revenue Per Share1.262.17471.294
Slightly volatile
Interest Debt Per Share1.051.96840.9315
Slightly volatile
Debt To Assets0.270.43630.2959
Slightly volatile
Operating Cycle162226198
Very volatile
Days Of Payables Outstanding149107156
Slightly volatile
Ebt Per Ebit1.291.09741.1226
Slightly volatile
Quick Ratio2.162.942.0872
Slightly volatile
Net Income Per E B T1.11.00061.0157
Pretty Stable
Cash Ratio1.62.35181.1021
Slightly volatile
Cash Conversion Cycle12511948.7811
Slightly volatile
Days Of Inventory Outstanding107162103
Slightly volatile
Days Of Sales Outstanding75.6464.189496.2371
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.331.07181.2163
Very volatile
Fixed Asset Turnover6.934.67827.6477
Slightly volatile
Debt Ratio0.270.43630.2959
Slightly volatile
Price Sales Ratio2.132.24414.19
Slightly volatile
Asset Turnover0.360.53580.4586
Slightly volatile
Gross Profit Margin0.660.58270.593
Slightly volatile

Akoya Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap422 M216.8 M525 M
Slightly volatile
Enterprise Value394 M219.4 M459 M
Slightly volatile

Akoya Fundamental Market Drivers

Cash And Short Term Investments83.1 M

Akoya Upcoming Events

4th of March 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Akoya Biosciences Financial Statements

Akoya Biosciences stakeholders use historical fundamental indicators, such as Akoya Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Akoya Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Akoya Biosciences' assets and liabilities are reflected in the revenues and expenses on Akoya Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Akoya Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue6.7 M5.6 M
Total Revenue96.6 M68.4 M
Cost Of Revenue40.3 M27.9 M
Stock Based Compensation To Revenue 0.11  0.11 
Sales General And Administrative To Revenue 0.54  0.48 
Research And Ddevelopement To Revenue 0.23  0.20 
Capex To Revenue 0.04  0.04 
Revenue Per Share 2.17  1.26 
Ebit Per Revenue(0.60)(0.63)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup
When determining whether Akoya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akoya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akoya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akoya Biosciences Stock:
How To Invest In Akoya
Details
Is Akoya Stock a good investment?
Details
What is Akoya Biosciences' Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Akoya Biosciences Correlation against competitors.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akoya Biosciences. If investors know Akoya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akoya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.16)
Revenue Per Share
1.889
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.18)
Return On Equity
(1.28)
The market value of Akoya Biosciences is measured differently than its book value, which is the value of Akoya that is recorded on the company's balance sheet. Investors also form their own opinion of Akoya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Akoya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akoya Biosciences' market value can be influenced by many factors that don't directly affect Akoya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Akoya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akoya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akoya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY